Log in to search using one of your social media accounts:

 

This is not a special effect: New video shows the destruction of a rogue cell
In the latest video of ourCells series, part of the GOBOLDLY ™ campaign, we witness the destruction of a rogue cell that causes rheumatoid arthritis (RA), a disease that affects 1.3 million Americans. (Source: The Catalyst)
Source: The Catalyst - April 10, 2017 Category: Pharmaceuticals Tags: Rheumatoid Arthritis GoBoldly Source Type: news

Obesity May Make Rheumatoid Arthritis Tough to Spot, Track
Inflammation from excess weight could lead doctors to think disease is worse in women than it is, study finds Source: HealthDay Related MedlinePlus Pages: Obesity, Rheumatoid Arthritis, Women's Health (Source: MedlinePlus Health News)
Source: MedlinePlus Health News - April 10, 2017 Category: Consumer Health News Source Type: news

Obesity May Make Rheumatoid Arthritis Tough to Spot, Track
MONDAY, April 10, 2017 -- Blood tests to diagnose and monitor rheumatoid arthritis may be thrown off by obesity in women, a new study suggests. " Physicians might assume that high levels of inflammation mean that a patient has rheumatoid arthritis... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - April 10, 2017 Category: Journals (General) Source Type: news

Obesity May Make Rheumatoid Arthritis Tough to Spot, Track
Title: Obesity May Make Rheumatoid Arthritis Tough to Spot, TrackCategory: Health NewsCreated: 4/10/2017 12:00:00 AMLast Editorial Review: 4/10/2017 12:00:00 AM (Source: MedicineNet Arthritis General)
Source: MedicineNet Arthritis General - April 10, 2017 Category: Rheumatology Source Type: news

Obesity may skew results of rheumatoid arthritis blood tests in women
Doctors should factor this in when using these tests, say researchers Related items fromOnMedica Breastfeeding may halve rheumatoid arthritis risk Drug for rheumatoid arthritis appears to have effect on severe eczema Transforming MSK care and patient outcomes If an anti-TNF fails to treat RA, try a non-TNF biologic Experts criticise arthritis patient referral delays (Source: OnMedica Latest News)
Source: OnMedica Latest News - April 10, 2017 Category: UK Health Source Type: news

RA medicines often demonstrate far greater benefits to patients than initially understood
In thelast decade, new therapies to treat rheumatoid arthritis (RA), a progressive and painful autoimmune disorder, have expanded patients ’ treatment options and significantly improved outcomes, helping people with RA achieve disease remission, avoid disability and experience an improved quality of life. And since the approval of these therapies and biologics, clinical evidence has grown, and these treatments are demonstrating far g reater benefits to patients than understood at the time of their initial approval. (Source: The Catalyst)
Source: The Catalyst - April 5, 2017 Category: Pharmaceuticals Tags: Value Rheumatoid Arthritis Value-Driven Health Care The Value Collaborative Source Type: news

Pedometers increase activity and decrease fatigue in rheumatoid arthritis patients
(Wiley) Providing pedometers, with and without providing step targets, to individuals with rheumatoid arthritis increased activity levels and decreased fatigue in a recent study. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - April 5, 2017 Category: Global & Universal Source Type: news

British Society of Rheumatology Prizes - Congratulations!
Michael Mason PrizeWe would like to say congratulations to Dr Francesca Barone (University of Birmingham) for being awarded theMichael Mason Prize by the British Society of Rheumatology. This prize is awarded by the Herberden Committee for excellence in clinical or scientific research in the field of rheumatology.Dr Francesca Barone holds anArthritis Research UK senior research fellowship. She is working to improve understanding of Sjögren’s syndrome, by looking at tertiary lymphoid organs that reside in the salivary glands. As well as answering why these structures are present, and whether removal of these stru...
Source: Arthritis Research UK - April 3, 2017 Category: Rheumatology Source Type: news

April 2017
Painful Joints?: Early Treatment for Rheumatoid Arthritis Is Key...Keep Your Voice Sound: How to Prevent and Avoid Voice Problems...Reducing Underage Drinking Among American Indians...How Cancer Cells Spread in the Body...Featured Web Site: Understanding Drug-Supplement Interactions (Source: NIH News in Health)
Source: NIH News in Health - March 31, 2017 Category: Consumer Health News Source Type: news

What Is RA? Consequences of Changed Classification Criteria What Is RA? Consequences of Changed Classification Criteria
What are the potential consequences of new classification criteria for rheumatoid arthritis?Annals of the Rheumatic Diseases (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - March 31, 2017 Category: Consumer Health News Tags: Rheumatology Journal Article Source Type: news

Get Good Gut Health With Prebiotics And Probiotics
We all want our gut to feel good. No one wants a gut that is in constant turmoil possibly leading to serious conditions of Crohn’s disease, ulcerative colitis, diabetes, obesity or rheumatoid arthritis. What our gut is trying to tell us when these diseases arise is that the gut’s microbiome, partly inherited from your mother at birth and partly determined by your lifestyle, have a great deal of influence on our health. Our gut microbiome is made of up bacteria, all good, that live within our intestines helping us digest our food. Digestion is serious business as these microbes munch away making essential vitami...
Source: Healthy Living - The Huffington Post - March 30, 2017 Category: Consumer Health News Source Type: news

New drug could fight symptoms of rheumatoid arthritis - including joint pain and swelling
RHEUMATOID arthritis could be treated with a new oral medicine for patients with moderate to severe cases of the condition. (Source: Daily Express - Health)
Source: Daily Express - Health - March 30, 2017 Category: Consumer Health News Source Type: news

Active Partners in Research
As companies increasingly integrate patient input into their R&D activities, they are coming to realize that they must also forge strong partnerships with patients and their families if they are to deliver truly patient-centered care. Yet, how do you transform buzzwords like patient engagement, patient voices, patient partnerships from theory into practice?It starts with being more systematic, says Danielle Gerlag, Patient Engagement Lead at  GlaxoSmithKline. “Over the last 10-15 years, we’ve done a lot to get the patient’s voice heard within GSK and there are pockets of excellence where we have ...
Source: EyeForPharma - March 29, 2017 Category: Pharmaceuticals Authors: Deirdre Coleman Source Type: news

Xeljanz Approved for Rheumatoid Arthritis in European Union Xeljanz Approved for Rheumatoid Arthritis in European Union
Xeljanz has received marketing authorization from the European Commission for the treatment of patients with moderate-to-severe RA, providing a new oral treatment option for these patients.International Approvals (Source: Medscape Allergy Headlines)
Source: Medscape Allergy Headlines - March 28, 2017 Category: Allergy & Immunology Tags: Rheumatology News Alert Source Type: news

Moderate drinking 'does not risk liver damage for methotrexate users'
People receiving the common rheumatoidarthritis therapymethotrexate can safely drink moderate amounts of alcohol without running the risk of liver damage. This is according to a new study from the University of Manchester, funded by Arthritis Research UK, which shows that drinking 14 units of alcohol or fewer per week is not likely to cause any liver health issues. Sticking to modest levels of drinking'likely to be safe' Methotrexate is often taken over extended periods of time to limit or prevent joint damage and disability associated withrheumatoid arthritis. Generally, those receiving the drug are advised to abs...
Source: Arthritis Research UK - March 28, 2017 Category: Rheumatology Source Type: news

Rheumatoid arthritis: Taking THIS drug with too much alcohol could be dangerous cocktail
RHEUMATOID arthritis sufferers taking particular medication are being warned not to drink too much alcohol - because they could be at increased risk of liver damage. (Source: Daily Express - Health)
Source: Daily Express - Health - March 28, 2017 Category: Consumer Health News Source Type: news

EC approves Pfizer's Xeljanz to treat rheumatoid arthritis in EU
The European Commission (EC) has approved Pfizer's Xeljanz (tofacitinib citrate) oral tablets to treat moderate-to-severe active rheumatoid arthritis (RA) in adult patients in the European Union (EU). (Source: Pharmaceutical Technology)
Source: Pharmaceutical Technology - March 27, 2017 Category: Pharmaceuticals Source Type: news

Travelling-wave ion mobility mass spectrometry elucidates structures of gold fingers
Drugs containing gold have been used for centuries to treat conditions like rheumatoid arthritis. In addition, they might be effective against cancer and HIV. One mechanism by which they work could occur because gold ions force the zinc ions out of zinc fingers -- looped, nucleic acid binding protein domains. American researchers have characterized such'gold fingers'using ion mobility mass spectrometry. They identified the exact gold binding sites. (Source: ScienceDaily Headlines)
Source: ScienceDaily Headlines - March 27, 2017 Category: Science Source Type: news

XELJANZ ® (tofacitinib citrate) receives marketing authorisation in the European Union for the treatment of moderate to severe active rheumatoid arthritis
Pfizer Inc. (NYSE:PFE) announced today that the European Commission (EC) has approved XELJANZ® (tofacitinib citrate) 5 mg twice daily (BID) oral tablets in combination with methotrexate (MTX) for the treatment of moderate to severe active rheumatoid arthritis (RA) in adult patients who have responded inadequately to, or who are intolerant to one or more disease-modifying antirheumatic drugs (DMARDs). (Source: World Pharma News)
Source: World Pharma News - March 27, 2017 Category: Pharmaceuticals Tags: Featured Pfizer Business and Industry Source Type: news

Remicade for Rheumatoid Arthritis Treatment
(Source: eMedicineHealth.com)
Source: eMedicineHealth.com - March 27, 2017 Category: Journals (General) Source Type: news

Mobile gold fingers
(Wiley) Drugs containing gold have been used for centuries to treat conditions like rheumatoid arthritis. In addition, they might be effective against cancer and HIV. One mechanism by which they work could occur because gold ions force the zinc ions out of zinc fingers -- looped, nucleic acid binding protein domains. American researchers have characterized such 'gold fingers' using ion mobility mass spectrometry. As reported in the journal Angewandte Chemie, they identified the exact gold binding sites. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - March 27, 2017 Category: Global & Universal Source Type: news

European Commission Approves AMGEVITA ™ (Biosimilar Adalimumab) For The Treatment Of Certain Inflammatory Diseases
First Biosimilar Adalimumab Approved in the European Union THOUSAND OAKS, Calif., March 23, 2017 /PRNewswire/ -- Amgen (NASDAQ:AMGN) today announced that the European Commission (EC) has granted marketing authorization for AMGEVITA™ (biosimilar adalimumab1) in all available indications. AMGEVITA is authorized for the treatment of certain inflammatory diseases in adults, including moderate-to-severe rheumatoid arthritis; psoriatic arthritis; severe active ankylosing spondylitis (AS); severe axial spondyloarthritis without radiographic evidence of AS; moderate-to-severe chronic plaque psoriasis; moderate-to-s...
Source: Amgen News Release - March 23, 2017 Category: Pharmaceuticals Tags: Uncategorized Source Type: news

New tool to treat rheumatoid arthritis discovered
A Swedish study suggests antibodies against the cartilage protein collagen II could aid in predicting prognosis and therapy choice for rheumatoid arthritis. (Source: Health News - UPI.com)
Source: Health News - UPI.com - March 23, 2017 Category: Consumer Health News Source Type: news

New tool for prognosis and choice of therapy for rheumatoid arthritis
(Uppsala University) In rheumatoid arthritis, antibodies are formed that affect the inflammation in the joints. In an article published today in the journal Annals of the Rheumatic Diseases, researchers at Uppsala University show that antibodies against the cartilage protein collagen II are associated with a good prognosis. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - March 23, 2017 Category: Global & Universal Source Type: news

New biomarker 'could aid prediction of rheumatoid arthritis outcomes'
A new biomarker has been discovered that could make it easier to predict which rheumatoidarthritis patients are most likely to experience a positive prognosis. Researchers at Uppsala University have carried out a study showing that antibodies against the cartilage protein collagen II are associated with better outcomes, and could be helpful in determining the best treatment to use for each patient. A link between collagen antibodies and disease development For this study, a large group ofrheumatoid arthritis patients were followed over five years to establish a possible correlation between collagen antibody levels and dise...
Source: Arthritis Research UK - March 23, 2017 Category: Rheumatology Source Type: news

New Enterprise Associates gets in on SetPoint Medical
SetPoint Medical said today that it has received an investment from venture capital firm New Enterprise Associates. SetPoint is developing a neuromodulation device designed to stimulate the vagus nerve to trigger the body’s anti-inflammatory response, according to the company. Newly vested NEA joins existing investors Medtronic (NYSE:MDT), Boston Scientific (NYSE:BSX), GlaxoSmithKline‘s (NYSE:GSK) Action Potential Venture Capital Limited, Morgenthaler Ventures and Topspin Partners. “We are proud that SetPoint has attracted such a prestigious and experienced investor. NEA is known for its support of c...
Source: Mass Device - March 20, 2017 Category: Medical Equipment Authors: Fink Densford Tags: Business/Financial News Neuromodulation/Neurostimulation SetPoint Medical Source Type: news

UCB works with Garmin on wellness program for rheumatoid arthritis patients
Global pharmaceutical company UCB has launched Wellness4U, a health and wellness platform for  people living with immunologic disorders which includes, as one aspect, an activity tracker pilot program. (Source: mobihealthnews)
Source: mobihealthnews - March 20, 2017 Category: Information Technology Source Type: news

Biologic-Naive PsA Patients Persist on Therapy (CME/CE)
(MedPage Today) -- Pattern similar to what is seen in rheumatoid arthritis (Source: MedPage Today Dermatology)
Source: MedPage Today Dermatology - March 19, 2017 Category: Dermatology Source Type: news

Oxford BioDynamics joins collaboration to identify biological factors that cause RA flares
UK-based biotechnology company Oxford BioDynamics has participated in a collaboration to identify biological factors that cause disease relapses, known as flares, in patients with rheumatoid arthritis (RA). (Source: Pharmaceutical Technology)
Source: Pharmaceutical Technology - March 17, 2017 Category: Pharmaceuticals Source Type: news

Modified red blood cells 'could alleviate autoimmune diseases'
This study is interesting and has the potential to be a tool used to both treat and prevent rheumatoid arthritis. It is promising to see that autoimmunity could be treated in mice, but people with arthritis need to be aware that this research is in its very early stages. "More research is needed to determine how the results can be translated into a benefit for people living inpain now, and for those who may develop arthritis in the future." (Source: Arthritis Research UK)
Source: Arthritis Research UK - March 17, 2017 Category: Rheumatology Source Type: news

What Chrissy Teigen Can Teach Us About Postpartum Depression
This reporting is brought to you by HuffPost’s health and science platform, The Scope. Like us on Facebook and Twitter and tell us your story: scopestories@huffingtonpost.com.    If you or someone you know needs help, call 1-800-273-8255 for the National Suicide Prevention Lifeline. You can also text HELLO to 741-741 for free, 24-hour support from the Crisis Text Line. Outside of the U.S., please visit the International Association for Suicide Prevention for a database of resources. -- This feed and its contents are the property of The Huffington Post, and use is subject to our t...
Source: Healthy Living - The Huffington Post - March 15, 2017 Category: Consumer Health News Source Type: news

Risk of Heart Failure Up for Rheumatoid Arthritis Patients
High disease activity linked to all types of heart failure, especially non - ischemic heart failure (Source: Pulmonary Medicine News - Doctors Lounge)
Source: Pulmonary Medicine News - Doctors Lounge - March 14, 2017 Category: Respiratory Medicine Tags: Cardiology, Family Medicine, Internal Medicine, Nursing, Pathology, Pulmonology, Rheumatology, Anesthesiology & Pain, Journal, Source Type: news

Rheumatoid Arthritis Drug May Not Ease Chronic Fatigue Syndrome After All
Title: Rheumatoid Arthritis Drug May Not Ease Chronic Fatigue Syndrome After AllCategory: Health NewsCreated: 3/6/2017 12:00:00 AMLast Editorial Review: 3/7/2017 12:00:00 AM (Source: MedicineNet Chronic Pain General)
Source: MedicineNet Chronic Pain General - March 7, 2017 Category: Anesthesiology Source Type: news

No Benefit of Rheumatoid Arthritis Drug in Chronic Fatigue Syndrome (FREE)
By Kelly Young Edited by David G. Fairchild, MD, MPH, and Jaye Elizabeth Hefner, MD The interleukin-1 receptor antagonist anakinra doesn't seem to reduce fatigue in women with chronic fatigue syndrome, according to … (Source: Physician's First Watch current issue)
Source: Physician's First Watch current issue - March 6, 2017 Category: Primary Care Source Type: news

Your NEJM Group Today: Histology Rings True / Probiotics for C. diff / Illinois IM Opportunity (FREE)
By the Editors Here's today's offering from NEJM Group:NEJM Clinical Practice Center: Clinical Problem-Solving: A 58-year-old man with nonerosive rheumatoid arthritis who was being treated with etanercept … (Source: Physician's First Watch current issue)
Source: Physician's First Watch current issue - March 6, 2017 Category: Primary Care Source Type: news

Rheumatoid Arthritis Drug May Not Ease Chronic Fatigue Syndrome After All
With disappointing study results, there's still no cure for the mysterious disorderSource: HealthDay Related MedlinePlus Pages: Chronic Fatigue Syndrome, Medicines (Source: MedlinePlus Health News)
Source: MedlinePlus Health News - March 6, 2017 Category: Consumer Health News Source Type: news

Rheumatoid Arthritis Drug May Not Ease Chronic Fatigue Syndrome After All
MONDAY, March 6, 2017 -- A small-scale clinical trial has cast doubt upon the potential usefulness of an anti-inflammatory drug to treat chronic fatigue syndrome. Doctors had hoped that anakinra (Kineret) -- a medication for rheumatoid arthritis --... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - March 6, 2017 Category: Journals (General) Source Type: news

Autoimmune Diseases Linked to Dementia Autoimmune Diseases Linked to Dementia
A new study linking autoimmune diseases, such as multiple sclerosis and rheumatoid arthritis, and later dementia strengthens the hypothesis that Alzheimer's may have an autoimmune component, researchers say.Medscape Medical News (Source: Medscape Neurology and Neurosurgery Headlines)
Source: Medscape Neurology and Neurosurgery Headlines - March 3, 2017 Category: Neurology Tags: Neurology & Neurosurgery News Source Type: news

Scientists discover new mechanism that leads to inflammation in rheumatoid arthritis
New research findings suggest that synovial CD4+ T cells that produce IL-21 contribute to joint inflammation by activating synovial fibroblasts in rheumatoid arthritis patients. (Source: ScienceDaily Headlines)
Source: ScienceDaily Headlines - March 2, 2017 Category: Science Source Type: news

Scientists discover metabolic pathway that drives tumor growth in aggressive cancers
(The Mount Sinai Hospital / Mount Sinai School of Medicine) Mount Sinai researchers have discovered that a rheumatoid arthritis drug can block a metabolic pathway that occurs in tumors with a common cancer-causing gene mutation, offering a new possible therapy for aggressive cancers with few therapeutic options, according to a study to be published in Cancer Discovery. (Source: EurekAlert! - Biology)
Source: EurekAlert! - Biology - March 2, 2017 Category: Biology Source Type: news

Scientists discover new mechanism that leads to inflammation in rheumatoid arthritis
(Federation of American Societies for Experimental Biology) New research findings published in the Journal of Leukocyte Biology (http://www.jleukbio.org), suggest that synovial CD4+ T cells that produce IL-21 contribute to joint inflammation by activating synovial fibroblasts in rheumatoid arthritis patients. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - March 2, 2017 Category: Global & Universal Source Type: news

Kevzara(TM) (sarilumab) now available in Canada for the Treatment of Adult Patients with Moderately to Severely Active Rheumatoid Arthritis
Comprehensive patient support program also announced MISSISSAUGA, ON, Feb. 28, 2017 (Healthcare Sales & Marketing Network) - Sanofi Genzyme, the specialty business unit of sanofi-aventis Canada Inc., is pleased to announced the Canadian availability of... Biopharmaceuticals, Product Launch Sanofi, Sanofi Genzyme, Regeneron Pharmaceuticals, Kevzara, sarilumab, arthritis (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - February 28, 2017 Category: Pharmaceuticals Source Type: news

Men 'face unique challenges when coping with rheumatoid arthritis'
Men with rheumatoidarthritis are often struggling to cope with their condition due to unique challenges created by their identities and self-perception, according to a new study. Research carried out by the University of West England and funded by Arthritis Research UK has indicated that men face specific problems when dealing mentally withrheumatoid arthritis that women do not share - and that tailored channels of support may be needed to help them cope. The unique struggles faced by men The study centred on a series of interviews carried out among six focus groups comprising 22 men, who were asked about their experiences...
Source: Arthritis Research UK - February 28, 2017 Category: Rheumatology Source Type: news

Binding immunoglobulin protein therapy shows promise for rheumatoid arthritis
A promising new approach to treating rheumatoidarthritis using binding immunoglobulin protein (BiP) therapy has shown its potential in a new clinical study. Carried out by King's College London and Guys and St Thomas' NHS Foundation Trust Hospital, the research has indicated that BiP-based treatment could represent a useful intervention for patients who have failed to respond to conventional disease-modifying antirheumaticdrugs (DMARDs). How it works BiP belongs to a class of compounds known as human endoplasmic reticulum-resident stress proteins, and has been shown in preclinical studies to offer anti-inflammatory...
Source: Arthritis Research UK - February 27, 2017 Category: Rheumatology Source Type: news

Masonic Charitable Foundation awards grant to microbiome research
The Masonic Charitable Foundation has awarded£90,000 over three years to Arthritis Research UK, to support research into the role of the microbiome in rheumatoid arthritis.The grant will support Dr Frances Williams at King’s College London, to explore whether the mix of bacteria in and on our bodies (known as the microbiome) drives rheumatoid arthritis, or whether changes in these bacteria are a consequence of the disease or the drugs used to treat it.The researchAround 400,000 people in the UK have rheumatoid arthritis but the best drugs available do not work for everyone. We know that the microbiome in people...
Source: Arthritis Research UK - February 27, 2017 Category: Rheumatology Source Type: news

Clues to relationship between schizophrenia and rheumatoid arthritis
A bioinformatics study identifies genetic variants with differing effects on risk of rheumatoid arthritis and schizophrenia. (Source: ScienceDaily Headlines)
Source: ScienceDaily Headlines - February 24, 2017 Category: Science Source Type: news

Pitt study provides clues to relationship between Schizophrenia and Rheumatoid arthritis
(University of Pittsburgh Schools of the Health Sciences) Bioinformatics study identifies genetic variants with differing effects on risk of rheumatoid arthritis and schizophrenia. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - February 24, 2017 Category: Global & Universal Source Type: news

New assay may lead to a cure for debilitating inflammatory joint disease
Current treatments for rheumatoid arthritis relieve the inflammation that leads to joint destruction, but the immunologic defect that triggers the inflammation persists to cause relapses. Known as autoantibodies and produced by the immune system's B cells, these defective molecules mistakenly attack the body's own proteins in an example of autoimmune disease. (Source: ScienceDaily Headlines)
Source: ScienceDaily Headlines - February 24, 2017 Category: Science Source Type: news

New assay may lead to a cure for debilitating inflammatory joint disease
(NYU Langone Medical Center / New York University School of Medicine) Current treatments for rheumatoid arthritis relieve the inflammation that leads to joint destruction, but the immunologic defect that triggers the inflammation persists to cause relapses. Known as autoantibodies and produced by the immune system's B cells, these defective molecules mistakenly attack the body's own proteins in an example of autoimmune disease. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - February 23, 2017 Category: Global & Universal Source Type: news